Navigation Links
Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
Date:7/20/2011

EAST BRUNSWICK, N.J., July 20, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that the Company will release financial results for the second quarter 2011 prior to the open of the market on Thursday, August 4, 2011.

John H. Johnson, Chief Executive Officer and President, and David Gionco, Group Vice President and Chief Financial Officer, will host an investment community conference call beginning at 9:00 a.m. Eastern Time on August 4, 2011, to discuss these results and to answer questions.

To participate by telephone, please dial 877-278-8171 (Domestic) or 574-941-7303 (International). The conference ID number is 84217509. The live and archived webcast can be accessed on the investor relations section of the Savient website at www.savient.com. Please log on to Savient's website fifteen minutes prior to the start of the call to ensure adequate time for any downloads that may be necessary.

A telephone replay will be available from 12:00 p.m. Eastern Time on August 4, 2011, through 12:00 a.m. Eastern Time on August 14, 2011, by dialing 855-859-2056 (Domestic) or 404-537-3406 (International) and entering conference ID number 84217509.

About Savient Pharmaceuticals, Inc.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP").  Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing a
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)...  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... quarter financial results on Tuesday, August 5, 2014, after ... host a live audio webcast immediately following the announcement ... business and financial update and discuss second quarter 2014 ... live audio webcast via the Investors & Media section ...
(Date:7/22/2014)... , July 22, 2014 Research ... "Cell Culture Market by Equipment, by Reagent, by ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... organisms. Cell culture is one of the most important ... also the largest application segment of the cell culture ...
(Date:7/22/2014)... 2014 Legislation backed by the drugstore ... Pharmacies Act of 2014") championing so-called "any willing ... the availability of lower cost preferred pharmacy networks ... the next 10 years, according to new research ... Care Management Association (PCMA). The drugstore ...
Breaking Medicine Technology:Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3New Study: H.R. 4577 to Cost $21 Billion over 10 Years 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 3
... A unique collaborative effort among business leaders and health ... nation for health care has led to more than $12.8 ... days spent in the hospital and nearly 3,600 fewer adverse ... Solutions for Patient Safety initiative, launched in January 2009 ...
... Jan. 18, 2011 WebMD Health Corp. (Nasdaq: ... health information, has launched its Medscape from WebMD ... and tablets.  Medscape Mobile is the premier free ... professionals.  Since its release on the iPhone® and ...
Cached Medicine Technology:Ohio Business, Health Care Leaders' Collaboration to Improve Patient Safety Results in Estimated Annual Savings of Nearly $13 Million 2Ohio Business, Health Care Leaders' Collaboration to Improve Patient Safety Results in Estimated Annual Savings of Nearly $13 Million 3WebMD Launches Medscape for iPad™ and Android™ Devices 2WebMD Launches Medscape for iPad™ and Android™ Devices 3
(Date:7/22/2014)... By Steven Reinberg ... -- Women who are obese during pregnancy may be more ... new review suggests. "We found that, compared with children ... overweight or obese during pregnancy had up to 20 to ... Erick Forno, an assistant professor of pediatrics at Children,s Hospital ...
(Date:7/22/2014)... the University of Utah,s John A. Moran Eye Center, ... Research (ISER) as the recipient of the Houston, Texas-based ... Retina Research., The award recognizes lifetime achievement by a ... the understanding of vitreoretinal diseases or disorders. The award ... Meeting in San Francisco, where Marc will deliver a ...
(Date:7/22/2014)... 22, 2014 SIMpalm, a ... payment app for Forte Payment System. Forte Mobile Payment ... payments on iPhone, iPod and iPad. The app ... recently updated by SIMpalm. This update was for iOS ... supported on iOS 4.3 and is available to download ...
(Date:7/22/2014)... Ticket Down is a reliable source for cheap Manchester ... MD. There has never been a better time in the ... success of the American national soccer team at the 2014 World ... that fans of the world’s sport will be able to feed ... Champions Cup. The tournament will kick off on July 24 and ...
(Date:7/22/2014)... July 22, 2014 (HealthDay News) -- One of the ... a psychiatric disorder has uncovered 83 new sites on ... The findings, made by an international team of researchers, ... linked to the disorder to 108. Although ... as a test to predict who will or will ...
Breaking Medicine News(10 mins):Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 2Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 3Health News:University of Utah researcher Robert Marc receives Paul Kayser International Award 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 3Health News:Gene Discoveries Could Shed New Light on Schizophrenia 2
... GPRC5A gene, which is under-expressed in human lung cancer cells, ... key to attacking lung cancer in humans, researchers at The ... the Nov. 21 edition of The Journal of the National ... of their GPRC5A genes suppressed developed normally until their second ...
... current laws are too cumbersome , , TUESDAY, Nov. 13 ... in their efforts to protect human research subjects, a ... doctors recently surveyed said that the Health Insurance Portability ... patients, medical information, has hindered research. Only one-quarter felt ...
... Sorting Out the Bitters , Maik Behrens, ... , The story goes that bitter taste receptors ... course, have diverse chemical structures. It has been debated ... whether we need multiple bitter receptors. Bitter taste is ...
... delivery ... technology., CLEVELAND, ... patented, 81 milligram aspirin tablet that,dissolves rapidly in the mouth instead ... of Americans who maintain a,daily aspirin routine and worry about gastrointestinal ...
... Heartburn Alliance Sponsors First Ever Heartburn Awareness Month, ... ... remains a burning problem,for more than 60 million Americans each month(1), ... for heartburn,education by sponsoring the first ever Heartburn Awareness Month. ...
... ... Tennis Champions, CHATHAM, N.J., Nov. 13 The Justin ... Jersey. The event will take place on two dates. On Sunday,December 9, ... tournaments with professional tennis champions. On Thursday,December 13, at 7 PM fans ...
Cached Medicine News:Health News:M. D. Anderson researchers identify tumor-suppressor gene for lung cancer 2Health News:Rules on Patients' Medical Data Hampering Research 2Health News:Rules on Patients' Medical Data Hampering Research 3Health News:News Tips from the Journal of Neuroscience 2Health News:News Tips from the Journal of Neuroscience 3Health News:New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen 2Health News:Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 2Health News:Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 3Health News:The Justin Gimelstob Children's Fund Hosts Tennis Exhibition 2
... is an intracorporeal electrokinetic lithotripter particularly ... VIBROLITH guarantees satisfaction in application to ... gall bladder and salivary gland stones. ... percutaneous applications. Kinetic energy transmitted by ...
Combination Ultrasonic and Pneumatic Urological Lithotriptor. Consists of four sizes of rigid pneumatic probes for use in the kidney, ureter and bladder....
... Multiline offers an ideal combination of ... easy and effective treatment of urinary ... wide range of urological applications. ... images enabling rapid, precise stone localization. ...
... MODULITH SLX is not only one of the ... versatile medical workstation. Apart from being designed for ... in the urinary tract, the MODULITH SLX can ... endourological therapies. It is equally suitable for the ...
Medicine Products: